...
首页> 外文期刊>Frontiers in Neurology >Autonomic Neuropathy—a Prospective Cohort Study of Symptoms and E/ I Ratio in Normal Glucose Tolerance, Impaired Glucose Tolerance, and Type 2 Diabetes
【24h】

Autonomic Neuropathy—a Prospective Cohort Study of Symptoms and E/ I Ratio in Normal Glucose Tolerance, Impaired Glucose Tolerance, and Type 2 Diabetes

机译:自主神经病-正常葡萄糖耐量,糖耐量受损和2型糖尿病的症状和 E / I 比率的前瞻性队列研究

获取原文

摘要

Background Autonomic neuropathy in diabetes, in addition to causing a range of symptoms originating from the autonomic nervous system, may increase cardiovascular morbidity. Our aim was to study the progression of autonomic neuropathy, based on symptom score and evaluation of an autonomic test, in persons with normal and impaired glucose tolerance and in patients with type 2 diabetes (T2D). Methods Participants were recruited in 2003/2004 with a follow-up in 2014. The participants’ glucose tolerance was categorized using oral glucose tolerance tests. Symptoms were evaluated using an autonomic symptom score (ASS), ECG was used to test cardiac autonomic function based on the expiration/inspiration ratio ( E / I ratio), and blood samples were taken on both occasions. Results ASSs were higher at follow-up in the T2D patients than in the normal glucose tolerance group (mean 1.21?±?1.30 vs. 0.79?±?0.7; p ?
机译:背景技术糖尿病中的自主神经病变除了会引起一系列源自自主神经系统的症状外,还可能增加心血管疾病的发病率。我们的目标是基于症状评分和自动测试的评估,在糖耐量正常和受损的人群以及2型糖尿病(T2D)患者中研究自主神经病变的进展。方法于2003/2004年招募参与者,并于2014年进行随访。参与者的口服糖耐量通过口服糖耐量测试进行分类。使用自主神经症状评分(ASS)评估症状,根据呼气/吸气比(E / I比),使用ECG来测试心脏自主神经功能,并在两种情况下均采集血样。结果T2D患者随访时的ASS高于正常的糖耐量组(平均1.21±±1.30 vs. 0.79±±0.7; p <0.05)。 E / I比率的劣化并未超过可控T2D中的老化效应。在E / I比值与HbA1c或ASS之间未发现任何关系。结论T2D患者的自主神经症状随着时间的推移而增加,但在该代谢良好的队列研究中,该症状与E / I比无关。在评估葡萄糖代谢异常患者的自主神经功能障碍的进展时,ASS可能是有用的临床工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号